Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs

Ho Chul Shin, Adam W.G. Alani, Deepa A. Rao, Nicole Rockich Winston, Glen S. Kwon

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Current clinical and preclinical anticancer formulations are limited by their use of toxic excipients and stability issues upon combining different drug formulations. We have found that poly(ethylene glycol)-block-poly(d,l lactic acid) (PEG-b-PLA) micelles can deliver multiple poorly water-soluble drugs at clinically relevant doses. Paclitaxel (PTX), etoposide (ETO), docetaxel (DCTX) and 17-allylamino-17-demethyoxygeldanamycin (17-AAG) were solubilized individually in PEG-b-PLA micelles. Combinations of PTX/17-AAG, ETO/17-AAG, DCTX/17-AAG and PTX/ETO/17-AAG were also solubilized in PEG-b-PLA micelles. PEG-b-PLA micelles were characterized in terms of drug loading, size, stability and drug release. All anticancer agents in all combinations were all solubilized at the level of mg/mL and were stable for 24 h in the 2- and 3-drug combination PEG-b-PLA micelles. The stability of the 2- and 3-drug combination PEG-b-PLA micelles was due to the presence of 17-AAG. In vitro, t1/2 values for 2- and 3-drug combination PEG-b-PLA micelles spanned 1-5 h. PEG-b-PLA micelles offer a promising alternative for combination drug therapy without formulation related side effects.

Original languageEnglish (US)
Pages (from-to)294-300
Number of pages7
JournalJournal of Controlled Release
Volume140
Issue number3
DOIs
StatePublished - Dec 16 2009
Externally publishedYes

Fingerprint

Ethylene Glycol
Micelles
docetaxel
Pharmaceutical Preparations
Etoposide
Drug Combinations
Paclitaxel
Drug Compounding
poly(lactic acid)
Excipients
Poisons
Combination Drug Therapy
Antineoplastic Agents
Water

Keywords

  • Combination drug therapy
  • Cremophor EL
  • Drug solubilization
  • Heat shock protein 90 inhibitor
  • Polymeric micelle

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. / Shin, Ho Chul; Alani, Adam W.G.; Rao, Deepa A.; Winston, Nicole Rockich; Kwon, Glen S.

In: Journal of Controlled Release, Vol. 140, No. 3, 16.12.2009, p. 294-300.

Research output: Contribution to journalArticle

Shin, Ho Chul ; Alani, Adam W.G. ; Rao, Deepa A. ; Winston, Nicole Rockich ; Kwon, Glen S. / Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. In: Journal of Controlled Release. 2009 ; Vol. 140, No. 3. pp. 294-300.
@article{afd45e53c2c74f8a8499207f093bacfb,
title = "Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs",
abstract = "Current clinical and preclinical anticancer formulations are limited by their use of toxic excipients and stability issues upon combining different drug formulations. We have found that poly(ethylene glycol)-block-poly(d,l lactic acid) (PEG-b-PLA) micelles can deliver multiple poorly water-soluble drugs at clinically relevant doses. Paclitaxel (PTX), etoposide (ETO), docetaxel (DCTX) and 17-allylamino-17-demethyoxygeldanamycin (17-AAG) were solubilized individually in PEG-b-PLA micelles. Combinations of PTX/17-AAG, ETO/17-AAG, DCTX/17-AAG and PTX/ETO/17-AAG were also solubilized in PEG-b-PLA micelles. PEG-b-PLA micelles were characterized in terms of drug loading, size, stability and drug release. All anticancer agents in all combinations were all solubilized at the level of mg/mL and were stable for 24 h in the 2- and 3-drug combination PEG-b-PLA micelles. The stability of the 2- and 3-drug combination PEG-b-PLA micelles was due to the presence of 17-AAG. In vitro, t1/2 values for 2- and 3-drug combination PEG-b-PLA micelles spanned 1-5 h. PEG-b-PLA micelles offer a promising alternative for combination drug therapy without formulation related side effects.",
keywords = "Combination drug therapy, Cremophor EL, Drug solubilization, Heat shock protein 90 inhibitor, Polymeric micelle",
author = "Shin, {Ho Chul} and Alani, {Adam W.G.} and Rao, {Deepa A.} and Winston, {Nicole Rockich} and Kwon, {Glen S.}",
year = "2009",
month = "12",
day = "16",
doi = "10.1016/j.jconrel.2009.04.024",
language = "English (US)",
volume = "140",
pages = "294--300",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs

AU - Shin, Ho Chul

AU - Alani, Adam W.G.

AU - Rao, Deepa A.

AU - Winston, Nicole Rockich

AU - Kwon, Glen S.

PY - 2009/12/16

Y1 - 2009/12/16

N2 - Current clinical and preclinical anticancer formulations are limited by their use of toxic excipients and stability issues upon combining different drug formulations. We have found that poly(ethylene glycol)-block-poly(d,l lactic acid) (PEG-b-PLA) micelles can deliver multiple poorly water-soluble drugs at clinically relevant doses. Paclitaxel (PTX), etoposide (ETO), docetaxel (DCTX) and 17-allylamino-17-demethyoxygeldanamycin (17-AAG) were solubilized individually in PEG-b-PLA micelles. Combinations of PTX/17-AAG, ETO/17-AAG, DCTX/17-AAG and PTX/ETO/17-AAG were also solubilized in PEG-b-PLA micelles. PEG-b-PLA micelles were characterized in terms of drug loading, size, stability and drug release. All anticancer agents in all combinations were all solubilized at the level of mg/mL and were stable for 24 h in the 2- and 3-drug combination PEG-b-PLA micelles. The stability of the 2- and 3-drug combination PEG-b-PLA micelles was due to the presence of 17-AAG. In vitro, t1/2 values for 2- and 3-drug combination PEG-b-PLA micelles spanned 1-5 h. PEG-b-PLA micelles offer a promising alternative for combination drug therapy without formulation related side effects.

AB - Current clinical and preclinical anticancer formulations are limited by their use of toxic excipients and stability issues upon combining different drug formulations. We have found that poly(ethylene glycol)-block-poly(d,l lactic acid) (PEG-b-PLA) micelles can deliver multiple poorly water-soluble drugs at clinically relevant doses. Paclitaxel (PTX), etoposide (ETO), docetaxel (DCTX) and 17-allylamino-17-demethyoxygeldanamycin (17-AAG) were solubilized individually in PEG-b-PLA micelles. Combinations of PTX/17-AAG, ETO/17-AAG, DCTX/17-AAG and PTX/ETO/17-AAG were also solubilized in PEG-b-PLA micelles. PEG-b-PLA micelles were characterized in terms of drug loading, size, stability and drug release. All anticancer agents in all combinations were all solubilized at the level of mg/mL and were stable for 24 h in the 2- and 3-drug combination PEG-b-PLA micelles. The stability of the 2- and 3-drug combination PEG-b-PLA micelles was due to the presence of 17-AAG. In vitro, t1/2 values for 2- and 3-drug combination PEG-b-PLA micelles spanned 1-5 h. PEG-b-PLA micelles offer a promising alternative for combination drug therapy without formulation related side effects.

KW - Combination drug therapy

KW - Cremophor EL

KW - Drug solubilization

KW - Heat shock protein 90 inhibitor

KW - Polymeric micelle

UR - http://www.scopus.com/inward/record.url?scp=70449711530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449711530&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2009.04.024

DO - 10.1016/j.jconrel.2009.04.024

M3 - Article

VL - 140

SP - 294

EP - 300

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -